Krystal Biotech Cash Flow Statement (2021-2025) | KRYS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -15.81M-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-45.30M80.75M8.69M0.93M15.57M27.17M45.51M35.70M38.33M79.37M
Depreciation and Depletion 0.44M0.47M0.47M0.45M0.46M0.49M0.67M1.04M1.10M1.20M1.20M1.51M1.43M1.80M1.30M1.40M1.41M1.30M1.40M
Share-based Compensation 2.31M4.20M3.67M5.14M6.43M8.19M9.06M9.55M10.44M11.33M8.31M9.85M9.30M13.16M13.32M13.36M13.48M14.12M13.15M
Gains from Investment Securities 1.49M2.57M0.34M1.39M0.16M0.81M1.58M1.50M1.21M1.21M1.65M2.29M0.92M1.80M12.06M0.02M
Cash from Operations -9.65M-10.13M-7.25M-20.90M-15.49M-43.06M-19.69M-22.33M-26.16M-34.19M-21.23M-7.23M15.89M-4.17M58.86M52.84M30.97M52.73M39.66M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.22M0.22M0.23M0.23M0.18M0.19M0.19M0.19M0.22M0.19M0.21M
Depreciation & Amortization (CF) 0.54M0.67M0.78M0.78M1.01M0.98M0.97M1.09M0.70M1.04M0.83M1.51M1.43M1.80M1.30M1.40M1.41M1.30M1.40M
Change in Working Capital
Change in Receivables 9.32M32.72M4.43M56.77M-5.94M7.45M-1.49M8.18M17.92M
Change in Inventory 0.91M3.08M0.49M2.24M-0.53M3.68M6.52M1.40M-0.88M4.71M
Change in Account Payables 0.29M-0.97M0.46M0.94M-0.55M0.58M-0.34M-0.94M0.11M0.37M-0.36M-0.22M0.73M0.78M0.09M-0.59M0.91M4.12M-4.02M
Change in Accured Expenses 0.28M2.52M3.93M-4.02M2.01M0.46M0.54M2.16M-3.46M1.80M2.54M3.68M-5.16M1.13M1.94M7.48M3.69M-1.29M5.92M
Other Working Capital Changes -1.31M-0.05M0.33M1.73M-0.82M-0.03M-0.18M1.65M0.13M0.52M-0.18M1.15M-0.24M2.74M-0.52M6.93M2.98M-0.02M1.35M
Investing Activities
Capital Expenditures 2.62M7.53M17.31M40.88M17.19M16.52M14.06M5.22M11.87M-0.87M0.10M0.70M8.46M0.11M-0.28M0.20M6.20M1.90M1.70M
Sales of Property, Plant and Equipment 0.43M
Change in Acquisitions & Divestments 1.73M1.23M8.07M21.00M24.04M62.79M66.77M104.08M154.52M161.23M112.87M74.59M63.62M95.18M79.25M60.49M88.81M105.28M95.79M
Cash from Investing Activities -0.75M-62.32M-37.17M-126.54M-55.91M-38.22M-14.74M-5.21M3.56M-15.96M105.19M-10.16M-25.98M-19.35M-34.33M-83.78M-54.77M-10.53M-4.29M
Financing Activities
Cash from Financing Activities 144.30M-0.20M1.51M202.07M-0.54M30.70M2.12M3.07M1.47M185.27M13.39M2.62M10.58M10.64M3.37M2.43M-12.47M1.80M3.71M
Additional items
Exchange Rate Effect -0.04M-0.04M0.01M0.01M-0.14M0.19M-0.34M0.29M-0.59M0.17M1.06M-0.31M
Change in Cash 133.90M-72.64M-42.91M54.63M-71.94M-50.58M-32.31M-24.51M-21.16M135.13M97.37M-14.91M0.68M-13.22M28.18M-29.10M-36.09M45.06M38.77M
Beginning Cash Balance 268.27M402.17M329.53M286.61M341.25M269.30M218.72M186.41M161.90M140.75M275.88M373.24M358.33M359.01M345.79M373.97M344.87M308.77M353.83M
Free Cash Flow -12.27M-17.66M-24.57M-61.78M-32.68M-59.57M-33.74M-27.55M-38.02M-33.32M-21.33M-7.93M7.43M-4.28M59.13M52.64M24.77M50.83M37.95M
Net Cash Flow 133.90M-72.64M-42.91M54.63M-71.94M-50.58M-32.31M-24.47M-21.12M135.12M97.35M-14.77M0.49M-12.88M27.89M-28.51M-36.27M44.00M39.08M